Rx Bio, INC.
Biomedical research and development
Based in TN
🤖
AI Overview
With $160K in lobbying spend across 11 quarterly filings, Rx Bio, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2023.
$160K
Total Spend
3
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $90K |
| 2022 | $70K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
- •Promote RxBio's biomedical research and advancements among Congressional, Department of Defense and other federal stakeholders, with primary focus on the FY22 budget cycle and securing federal support
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.